Skip to main content
AI generated image of diverse immune cells interacting in a complex network

Cluster of Excellence ImmunoSensation³

We Explore Immune Diversity

The immune system is dynamic and diverse, across scales. Its structures, functions and dynamics depend on genetic and environmental influences, lifestyle, gender, previous illnesses and age. These influences are reflected at the molecular, the cellular and the systemic level of our body. The resulting constant change and natural diversity of the immune system is referred to as immune diversity. 

Immune diversity forms the basis for the adaptive performance of our immune system and enables an individual immune response to pathogens or tissue damage, as occurs in connection with Alzheimer's, cancer, heart attacks or rheumatism. The aim of ImmunoSensation3 is to better understand the variability of the immune system in order to enable individualized and precise approaches for diagnostics, prevention and therapy.

ImmunoSensation3 is a Cluster of Excellence at the University of Bonn, funded by the German Research Foundation (DFG). We address the immune system as a sensory organ for health, which we term the immune sensory system. We are immunologists, neurobiologists, systems biologists, biochemists, biophysicists and mathematicians from the Faculty of Medicine and the Faculty of Mathematics and Natural Sciences at the University of Bonn, the University Hospital Bonn (UKB) and the German Centre for Neurodegenerative Diseases (DZNE) of the Helmholtz Association.

Founded in 2012, ImmunoSensation is currently in its fifteenth year of funding. We will continue to pursue our mission of innovative science in immunology. Further, we link immunology to other systems, such as the metabolic system and the nervous system. Ultimately, we want to better understand the intimate connection between the immune sensory system and human health and disease.

Members & Publications

116
Members

4813
Publications

News

Mikrochip zur Wiederherstellung zentralen Sehvermögens bei fortgeschrittener Makuladegeneration.

News categories: Publication

Approval of a Novel Retinal Implant Technology

A novel retinal implant is offering people with geographic atrophy the opportunity to regain part of their central vision for the first time. Geographic atrophy is a severe late stage of age-related macular degeneration. An international research team led by Prof. Frank G. Holz of the UKB and the University of Bonn demonstrated in an international clinical trial that the majority of participants experienced significant improvements in visual acuity. The novel retinal implant technology has now received approval for routine clinical use in Europe, making it available beyond clinical trials.
View entry
Prof. Dr. Frank G. Holz – Director of the Department of Ophthalmology at the University Hospital Bonn (UKB) and Professor at the University of Bonn.

News categories: Honors & Funding

Frank Holz Nominated for the Science Breakthrough of the Year 2026

A remarkable achievement for the Faculty of Medicine at the University of Bonn: Prof. Dr. Frank G. Holz, Director of the Department of Ophthalmology at the UKB and Professor at the University of Bonn, has been shortlisted for the Falling Walls Science Breakthrough of the Year 2026 in the Life Sciences category. His project is now among the 30 most outstanding scientific innovations worldwide in this category, recognized by the prestigious Falling Walls Science Summit. Being shortlisted alone represents a significant international distinction.
View entry
Authors

News categories: Publication

The Gut as a Key Player in Immunotherapy for MS

B-cell depletion therapies, in which B cells of the immune system, which may drive disease activity in multiple sclerosis (MS), are temporarily removed, have contributed significantly to improved treatment for patients in recent years. Researchers from Bonn, along with their collaborators, have uncovered a previously unknown mechanism through which B-cell depletion therapies contribute to a better disease course in patients with MS. Surprisingly, the treatment appears to exert part of its beneficial effect by mobilizing regulatory immune cells that naturally reside in the gut.
View entry

Upcoming events

Insights

Immunosensation 360°

Follow us on a virtual tour into the institutes and laboratories of ImmunoSensation3!

The 360° experience allows you to embark on an exciting journey, exploring the diversity of immunological research performed at ImmunoSensation3. Let our scientists guide you through the sites of scientific excellence and introduce you to the amazing world of the immune system.

Multimedia report "Beyond the Boundaries"

In our multimedia report "Beyond the boundaries" we introduce some of our outstanding group leaders. We take a closer look on their scientific work and their career paths within ImmunoSensation3, highlighting their innovative research approaches as well as the excellent research environment at the University of Bonn.

 

The report introduces